Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857620 · ClinicalTrials.gov registry record · NA
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
A NA study of Malignant Neoplasm and Carcinoma, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 20
- Study locations
NCT03857620: Active NA study of Malignant Neoplasm and Carcinoma, sponsored by Alliance for Clinical Trials in Oncology.
NCT03857620 is a NA study of Malignant Neoplasm and Carcinoma that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 325 participants, below the 508-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (36% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03857620, a NA study of Malignant Neoplasm and Carcinoma, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies how well the use of a pre-surgical toolkit (OPTI-Surg) works in improving surgical care and outcomes in older participants with cancer. In many elderly patients, surgery can greatly affect physical condition and the ability to return to pre-surgery levels of physical functioning. Providing pre-surgical recommendations may help improve participants' recovery rate and functioning after surgery.
Primary Outcome
The CHAMPS questionnaire includes 41 questions that measures frequency and duration of activities. The primary endpoint is the estimated Caloric Expenditure Per Week measure from the CHAMPS, which is calculated by weighting the duration variable of the 28 exercise-related activities using the corresponding metabolic equivalents (METs) value, then multiplying by 60 to convert METs/minute to METs/hour, then multiplying by participant weight in kg/200 to calculate the caloric expenditure/week score
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Informational Intervention
- OTHER Informational Intervention with Coaching
Study Locations (20)
Minnesota
- Fairview Southdale Hospital - Edina
- Hennepin County Medical Center - Minneapolis
- North Memorial Medical Health Center - Robbinsdale
Georgia
- Augusta University Medical Center - Augusta
- Memorial Health University Medical Center - Savannah
Illinois
- Advocate Christ Medical Center - Oak Lawn
- Carle Cancer Center - Urbana
Iowa
- Iowa Methodist Medical Center - Des Moines
- Mercy Medical Center - Des Moines - Des Moines
Kansas
- University of Kansas Cancer Center - Kansas City
- University of Kansas Hospital-Westwood Cancer Center - Westwood
Louisiana
- LSU Healthcare Network / Metairie Multi-Specialty Clinic - Metairie
- Louisiana State University Health Science Center - New Orleans
Michigan
- Saint Joseph Mercy Hospital - Ann Arbor
- Spectrum Health at Butterworth Campus - Grand Rapids
Delaware
- Helen F Graham Cancer Center - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2019-07-24 |
| Est. Completion | 2025-10 |
| Phase | NA |
What the registry record for NCT03857620 still lists
NCT03857620 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 508-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (36% lower).
The record links to 4 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT03857620 names 20 study sites across 12 states, led by Minnesota, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT03857620 about?
NCT03857620 is a clinical study titled "Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer". This trial studies how well the use of a pre-surgical toolkit (OPTI-Surg) works in improving surgical care and outcomes in older participants with cancer. In many elderly patients, surgery can greatly affect physical condition and the ability to return to pre-surgery levels of physical functioning. ...
What is the current status of trial NCT03857620?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2019-07-24. Estimated completion is 2025-10.
What conditions does trial NCT03857620 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Carcinoma, Surgical Procedure, Unspecified, Health Care Provider.
What interventions are being tested in trial NCT03857620?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Informational Intervention (OTHER), Informational Intervention with Coaching (OTHER).
Who is sponsoring clinical trial NCT03857620?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03857620 being conducted?
This trial has 20 study locations across Delaware, District of Columbia, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03857620's enrollment target sits among peer trials
325 15th of 59 higher than 45 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI